Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes

Código QR

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes

Michael A Via1, Himani Chandra2, Takako Araki1, Matthew V Potenza3, Maria Skamagas41Division of Endocrinology and Metabolism, Albert Einstein College of Medicine, Beth Israel Medical Center, New York, NY, USA; 2Division of Endocrinology, Diabetes and Bone Disease, Mount Sinai School of Medicine, Jam...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Michael A Via, Himani Chandra, Takako Araki, et al
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/8db9092bc7954a75aa607adcf098547f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
por: Via MA
Publicado: (2010)

Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes
por: Powell DR, et al.
Publicado: (2015)

Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes
por: Priyanka Gunasekara, et al.
Publicado: (2011)

Glycemic control and anti-osteopathic effect of propolis in diabetic rats
por: Al-Hariri M,&nbsp;Gamal Eldin T, et al.
Publicado: (2011)

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
por: Robert G Moses
Publicado: (2010)

Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics
por: Jean-Pierre Le Floch
Publicado: (2010)

The role of insulin glulisine to improve glycemic control in children with diabetes mellitus
por: Carter J, et al.
Publicado: (2010)

Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control
por: Di Pierro F, et al.
Publicado: (2012)

Myocardial perfusion imaging for evaluation of suspected ischemia and its relationship with glycemic control in South African subjects with diabetes mellitus
por: Shmendi A, et al.
Publicado: (2014)

Exenatide once weekly: sustained improvement in glycemic control and cardiometabolic measures through 3 years
por: MacConell L, et al.
Publicado: (2013)

Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis
por: Kostev K, et al.
Publicado: (2015)

Level of sustained glycemic control and associated factors among patients with diabetes mellitus in Ethiopia: a hospital-based cross-sectional study
por: Abebe SM, et al.
Publicado: (2015)

Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design
por: Thomas Strack, et al.
Publicado: (2009)

Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study
por: Penfornis A, et al.
Publicado: (2015)

Improving glycemic and cholesterol control through an integrated approach incorporating colesevelam &ndash; a clinical perspective
por: Ronald B Goldberg
Publicado: (2009)

Leukocyte peroxidase and leptin: an associated link of glycemic tolerance and bronchial asthma?
por: Sergio Parco
Publicado: (2010)

Relationship between oxidized low-density lipoprotein antibodies and obesity in different glycemic situations
por: Babakr AT, et al.
Publicado: (2014)

Poor Glycemic Control and Its Contributing Factors Among Type 2 Diabetes Patients at Adama Hospital Medical College in East Ethiopia
por: Yosef T, et al.
Publicado: (2021)

Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial
por: Srivanichakorn W, et al.
Publicado: (2015)

Lycopene Improves the Metformin Effects on Glycemic Control and Decreases Biomarkers of Glycoxidative Stress in Diabetic Rats
por: Figueiredo ID, et al.
Publicado: (2020)

Glycemic control and diabetes complications among diabetes mellitus patients attending at University of Gondar Hospital, Northwest Ethiopia
por: Fasil A, et al.
Publicado: (2018)

The Features of Pathobiology and Clinical translation of Approved treatments for Coronavirus Disease 2019 (COVID-19)
por: Ali Fallah, et al.
Publicado: (2021)

AMPK activation: a therapeutic target for type 2 diabetes?
por: Coughlan KA, et al.
Publicado: (2014)

TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
por: Zambad SP, et al.
Publicado: (2013)

Standardized Glycemic Management versus Conventional Glycemic Management and Postoperative Outcomes in Type 2 Diabetes Patients Undergoing Elective Surgery
por: Vongsumran N, et al.
Publicado: (2020)

Randomized, double-blind, placebo-controlled, clinical study on the effect of Diabetinol® on glycemic control of subjects with impaired fasting glucose
por: Evans M, et al.
Publicado: (2015)

Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus
por: Peter J Donovan, et al.
Publicado: (2010)

GABAergic system in the endocrine pancreas: a new target for diabetes treatment
por: Wan Y, et al.
Publicado: (2015)

Curcumin improves prostanoid ratio in diabetic mesenteric arteries associated with cyclooxygenase-2 and NF-&kappa;B suppression
por: Sirada Rungseesantivanon, et al.
Publicado: (2010)

Current management strategies to target the increasing incidence of diabetes within Pakistan [Corrigendum]
por: Basit A, et al.
Publicado: (2019)

Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study
por: Saunders WB, et al.
Publicado: (2016)

Glycemic Control, Diabetes Complications and Their Determinants Among Ambulatory Diabetes Mellitus Patients in Southwest Ethiopia: A Prospective Cross-Sectional Study
por: YimamAhmed M, et al.
Publicado: (2020)

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
por: Moses R
Publicado: (2010)

Diabetes and depression in Lebanon and association with glycemic control: a cross-sectional study
por: Ahmadieh H, et al.
Publicado: (2018)

Racial Variation in the Relationship of Glycemic Control with Fracture Risk in Elderly Patients with Diabetes
por: Figaro MK, et al.
Publicado: (2020)

Optimizing weight control in diabetes: antidiabetic drug selection
por: S Kalra, et al.
Publicado: (2010)

The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia
por: Alzaheb RA, et al.
Publicado: (2018)

Prolylcarboxypeptidase (PRCP) as a new target for obesity treatment
por: B Shariat-Madar, et al.
Publicado: (2010)

Role of glycemic control on hospital-related outcomes in patients with diabetes mellitus undergoing renal transplantation
por: Lamos EM, et al.
Publicado: (2017)

Leukocyte peroxidase and leptin: an associated link of glycemic tolerance and bronchial asthma?
por: Parco S
Publicado: (2010)